Replimune Group Amends Sales Agreement with Leerink Partners LLC
Replimune Group, Inc. (NASDAQ: REPL) recently announced changes to its Sales Agreement with Leerink Partners LLC. The amendment, dated November 25, 2024, modifies the existing agreement between the company and the agent. Originally initiated on August 3, 2023, the Sales Agreement allowed Replimune Group the flexibility to sell shares (referred to as the “Shares”) of ...
Publicado el: 2024-11-28 07:00:55
Autor: MarketBeat News, Fuente: etfdailynews
Compartir: 
